Naveen Kulkarni,
CEO,
Polyclone Bioservices Pvt Ltd
In charge of Polyclone’s science and strategy, Naveen comes with over 15 years of scientific & entrepreneurial experience in the drug discovery industry across USA, Australia and India. Prior to founding Polyclone, he served as the Director of Business Development at Philips Research, where he was associated with a portfolio of opportunities for new business creation in healthcare and energy. In his previous roles, he has risen through the ranks - from being a bench worker at an Australian research institute to heading the strategic business unit of an American drug discovery informatics company. He has conceptualized and developed novel solutions for accelerating drug discovery and directed teams consisting of experts from different domains including chemistry, proteomics and systems biology. He has been instrumental in conceiving new ideas that are the basis for Polyclone’s patent portfolio. He has been a speaker and presenter in several international conferences.
|
|
|